Bruce E. Gelb, MD

  • Specialty: Transplant Surgery
  • Language: English
  • Phone: 212-263-8134
View Locations

About Me

 


Conditions and Treatments

liver transplant, abdomen surgery, living donor, kidney donation, organ transplant, kidney transplant, pancreas transplant, liver cirrhosis, liver surgery, hepatitis, chronic liver disease, liver diseases
Show More Conditions
Learn more about conditions we treat at NYU Langone:
Hepatitis A, B & C

Credentials

Positions
  • Assistant Professor, Department of Surgery
  • Associate Medical Director, Patient Placement and Progression
  • Surgical Director, Kidney Transplant Program
  • Medical Director, Unit 14W
Board Certifications
  • American Board of Surgery - Surgery, 2008
Education and Training
  • Fellowship, University of California - San Francisco, Transplant Surgery, 2010
  • Residency, NYU Medical School, Surgery, 2008
  • MD from University Of Texas, 2003
Departments

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Locations and Appointments

View Insurance Plans Accepted
  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Amidacare
    • Amidacare
  • Centerlight
    • Centerlight
  • Cigna
    • Cigna EPO/POS
    • Cigna PPO
  • ElderPlan
    • ElderPlan
  • Emblem
    • Emblem Select Care Exchange
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield HealthPlus
    • Empire Blue Cross Blue Shield HealthPlus Essential
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis
    • Fidelis Child Health
    • Fidelis Essential
    • Fidelis Exchange
    • Fidelis Family Health
    • Fidelis Medicaid
    • Fidelis Medicare
  • GHI
    • GHI CBP
    • GHI HMO
  • HIP
    • HIP Access I
    • HIP Access II
    • HIP Child Health
    • HIP EPO/PPO
    • HIP Essential
    • HIP Family Health
    • HIP HMO
    • HIP Medicaid
    • HIP Medicare
    • HIP POS
  • HealthSmart
    • HealthSmart (WTC)
  • Healthfirst
    • Healthfirst
    • Healthfirst Essential
  • Hotel Trades
    • Hotel Trades
  • Humana
    • Humana Medicare
  • Local 1199
    • Local 1199 PPO
  • MagnaCare
    • MagnaCare PPO
  • Medicaid
    • NY Medicaid
  • Medicare
    • Medicare
  • MetroPlus
    • MetroPlus Child Health
    • MetroPlus Essential
    • MetroPlus Exchange Plans
    • MetroPlus Family Health
    • MetroPlus Medicaid
    • MetroPlus Medicare
  • MultiPlan/PHCS
    • MultiPlan/PHCS PPO
  • NYS
    • NYS Empire Plan
  • Oxford
    • Oxford Freedom
    • Oxford Liberty
    • Oxford Medicare
  • Railroad Medicare
    • Railroad Medicare
  • UHC
    • UnitedHealthcare Community & State Plan
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare Medicare
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
    • UnitedHealthcare Top Tier
  • VNS
    • Visiting Nurse Service (VNS) Medicare
  • WellCare
    • WellCare Child Health
    • WellCare Family Health
    • WellCare Medicaid
    • WellCare Medicare
  • Wellcare
    • Wellcare Exchange
NYU Transplant Associates

317 East 34th Street, 8th Floor
New York, NY 10016

Phone

212-263-8134

View Map
NYU Transplant Associates

550 First Avenue
New York, NY 10016

Phone

212-263-5800

View Map
NYU Transplant Associates

200 Old Country Rd
Mineola, NY 11501

Phone

212-263-8134

View Map

Research My Research

Interests

hepatitis C, immunosuppression

Academic Contact

Academic office

401-403 East 34th Street

Third Floor

New York, NY 10016

Phone

212-263-8134

Research Interests Timeline

These focus areas and their associated publications are derived from PubMed and the MeSH term library.
represents one publication
Loading...

Clinical Trials and Research Studies

  • A Phase 2a Randomized Open-Label Active Control Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de novo Kidney Transplant Recipients

    Learn More
View All Research Studies (1)

Publications

Read All Publications (31)

Related News

A Groundbreaking Face Transplant One Year Later
Read Story